September 24, 2021

Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19



Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19

View at DailyMotion

Leave a Reply

Your email address will not be published. Required fields are marked *

Connect us

Our social contacts